May 4, 2021 — The multidistrict litigation (MDL) handling the lawsuits against Bayer Monsanto Roundup is teeming with over 40,000 unresolved claims that plaintiffs have developed non-Hodgkins lymphoma after exposure to the herbicide. In re: Bayer Roundup Products Liability Litigation is seeing more plaintiffs decide to take their cases to trial because Bayer’s settlement offers are insufficient in providing the fair compensation they deserve.
Additionally, the Big Pharma company is falling under fire for its proposed settlement framework. Roundup Lawsuit Attorneys charge that there is not clear guidance within the framework making it especially confusing and unreliable which results in particularly harsh treatment to the vulnerable who are suffering from the brutal fallout from cancer.
Recently, Roundup Lawsuit lawyers have filed motions for clients with non-Hodgkins lymphoma looking to throw out a proposed settlement to the MDL, which would allow Roundup maker Bayer AG to continue selling the herbicide and protect it from future cancer lawsuits. Instead of resolving all the lawsuits together, the settlement allows Bayer’s lawyers to negotiate individually with each law firm.
So far, the juries of three different Roundup trials have delivered multimillion-dollar verdicts against Bayer AG.
Reference: “More than 40,000 Cancer Claims Remain Unresolved from Proposed Bayer Monsanto Roundup Weed Killer Lawsuit Settlement.” PR Newswire, Cision, 26 Apr. 2021, www.prnewswire.com/news-releases/more-than-40-000-cancer-claims-remain-unresolved-from-proposed-bayer-monsanto-roundup-weed-killer-lawsuit-settlement-301276971.html.
